CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Johnson & Johnson Company Snapshot
Johnson & Johnson operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Johnson & Johnson with three other major healthcare and pharmaceutical companies: Bristol-Myers Squibb Company (2016 sales of $19.43 billion of which 100% was Pharmaceuticals), Baxter International Inc. ($10.16 billion of which 62% was Hospital Products), and Novartis AG which is based in Switzerland (48.88 billion Swiss Francs [US$51.18 billion] of which 66% was innovative medicines).

Sales Analysis. During the year ended December of 2016, sales at Johnson & Johnson were $71.89 billion. This is an increase of 2.6% versus 2015, when the company's sales were $70.08 billion. Despite this increase, sales are still below the level achieved in 2014, when Johnson & Johnson reported sales of $74.34 billion. Sales of Pharmaceutical saw an increase that was more than double the company's growth rate: sales were up 6.5% in 2016, from $31.43 billion to $33.46 billion. Not all segments of Johnson & Johnson experienced an increase in sales in 2016: sales of Consumer fell 1.5% to $13.31 billion. Johnson & Johnson also experienced decreases in sales in Medical Devices and Diagnostics (down 0.1% to $25.12 billion) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Johnson & Johnson
  Stock Performance Chart for Johnson & Johnson
 
  Stock Data: Recent Stock Performance:
  Current Price (7/14/2017): 132.60
(Figures in U.S. Dollars)
1 Week 0.0%   13 Weeks -1.3%  
4 Weeks 6.1%   52 Weeks 7.8%  
 
Johnson & Johnson Key Data:
  Ticker: JNJ Country: United States
  Exchanges: NYSE FRA MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 71,891,000,000
(Year Ending Jan 2017).
Employees: 126,400
  Currency: U.S. Dollars Market Cap: 357,202,266,541
  Fiscal Yr Ends: December Shares Outstanding: 2,693,833,081
  Share Type: Common Closely Held Shares: 1,255,300
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.